Evolus financials
$7.99+0.38%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $297.2M | $266.3M | $202.1M | $148.6M | $99.7M | $56.5M | $34.9M | $0.00 |
| Gross profit | $197.1M | $182.3M | $137.6M | $89.8M | $56.1M | $38.2M | $26.9M | $0.00 |
| Gross margin | 66.3% | 68.5% | 68.1% | 60.4% | 56.3% | 67.6% | 77.1% | — |
| Operating income | -$32.7M | -$34.4M | -$49.2M | -$65.3M | -$38.1M | -$155.1M | -$94.8M | -$46.1M |
| Net income | -$51.6M | -$50.4M | -$61.7M | -$74.4M | -$46.8M | -$163.0M | -$90.0M | -$46.9M |
| Net margin | −17.4% | −18.9% | −30.5% | −50.1% | −47.0% | −288.3% | −257.8% | — |
| Diluted EPS | $-0.80 | $-0.81 | $-1.08 | $-1.33 | $-0.94 | $-4.83 | $-3.19 | $-1.92 |
| EBITDA | -$23.7M | -$29.1M | -$44.1M | -$55.9M | -$57.3M | -$61.0M | -$89.8M | -$35.6M |
| Operating cash flow | -$42.3M | -$18.0M | -$34.0M | -$84.9M | -$33.4M | -$57.9M | -$93.4M | -$25.7M |
| Free cash flow | -$50.7M | -$22.8M | -$35.6M | -$87.9M | -$34.4M | -$61.0M | -$98.0M | -$25.7M |
| Diluted shares | 64.5M | 62.0M | 56.9M | 56.1M | 49.8M | 33.7M | 28.2M | 24.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $53.8M | $87.0M | $62.8M | $53.9M | $146.3M | $102.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | $5.0M |
| Total debt | $179.6M | $166.3M | $156.6M | $111.7M | $110.6M | $153.0M |
| Total assets | $225.9M | $232.6M | $189.0M | $178.0M | $257.5M | $209.1M |
| Total liabilities | $249.0M | $227.0M | $209.7M | $159.5M | $175.6M | $282.0M |
| Shareholders' equity | -$23.1M | $5.5M | -$20.7M | $18.5M | $81.9M | -$73.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology